🔧 Techniques like cell wall engineering and CRISPR-Cas9 are enhancing production efficiency.
📈 Although initially resource-intensive, these methods promise high-quality proteins for therapeutic uses.
🤝 Collaboration across sectors is essential for scaling and ensuring commercial viability.
🌍 The future looks bright for plant-based bioproduction!
Introduction:
The article discusses the potential of plant cell-based bioproduction systems for the efficient production of recombinant proteins, highlighting recent technological advancements that position these systems as competitive alternatives to traditional microbial production platforms such as E. coli.
- Plant cell-based systems can produce proteins with proper folding and post-translational modifications, but scaling and optimizing production remain challenging.
- Recent advancements in cellular engineering, genome editing, and precise gene integration may enhance the efficacy of plant cell-based bioproduction.
- Cell wall engineering and improved screening methods are critical for streamlining protein production processes.
- Strategic protein design and optimization of foreign gene integration sites in plant genomes could resolve issues related to low protein productivity.
- To achieve commercial viability, further developments in scaling production and meeting regulatory standards are necessary.
Conclusion:
Overall, the article suggests that modern bioproduction technologies could elevate plant cell-based systems to a position where they can offer high-quality proteins in a commercially viable manner, potentially transforming the landscape of protein production in therapeutic and industrial contexts.
